14 reports

  • Orion Corporation: key facts
  • ORION CORPORATION

Effective January ##, 2016, the group' s operations are managed through four business divisions: pharmaceuticals, Covestro, consumer health, and crop science.

  • Healthcare
  • Pharmaceutical
  • Scandinavia
  • Market Size
  • Orion Corporation
  • ORION ENTERS INTO AGREEMENT WITH ASAHI KASEI PHARMA
  • ENDO PHARMA ENTERS INTO RESEARCH COLLABORATION WITH ORION

Summary Orion Corporation (Orion) is a developer of pharmaceuticals and diagnostic tests.The company develops, manufactures and markets human and veterinary pharmaceuticals, active pharmaceutical ingredients (APIs) and diagnostic tests. It focuses on developing pharmaceutical products for central nervous system disorders,...

  • Healthcare
  • Pharmaceutical
  • Finland
  • Company Financials
  • Orion Corporation
  • KEY COMPANIES IN THE PARKINSON'S MARKET, 2015
  • PRODUCT PROFILE - COMTAN

NEWRON PHARMACEUTICALS (2013B).

  • Mental Health
  • Pharmaceutical
  • Psychotic Disorder
  • Therapy
  • Orion Corporation

Pharmaceuticals Policy and Law, ##, ##-##.

  • Cardiovascular Disease
  • Pharmaceutical
  • Therapy
  • Japan
  • Orion Corporation
  • Business Segment: Pharmaceuticals
  • Pharma S.r.l. for distribution of Erdotin in Denmark.

Orion Corp (ORNBV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations.The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The...

  • Pharmaceutical
  • Finland
  • Company Financials
  • Orion Corporation
  • Business Segment: Pharmaceuticals
  • Pharma S.r.l. for distribution of Erdotin in Denmark.

Orion Oyj (ORNBV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The...

  • Pharmaceutical
  • Finland
  • Company Financials
  • Orion Corporation
  • 6.37 FEB 13, 2017: CHANGE IN ORION GROUP EXECUTIVE MANAGEMENT BOARD AS OF 21 FEBRUARY 2017
  • 6.38 FEB 08, 2017: ORION GROUP FINANCIAL STATEMENT RELEASE FOR 2016

The Pharmaceuticals business' s net sales were up by ##% at EUR ##, ## (##, ##) million.

  • Pharmaceutical
  • United States
  • Company Financials
  • Demand
  • Orion Corporation
  • Passport 13
  • International Players Dominate the Fragmented Consumer Health

The Fermion subsidiary produces active pharmaceutical ingredients for both Orion and other pharmaceutical companies.

  • OTC
  • Pharmaceutical
  • Finland
  • Demand
  • Orion Corporation
  • Jan 27, 2017: Reijo Salonen, Senior Vice President, Pharmaceutical R&D, is CTO of the Year 2017
  • Apr 11, 2017: Pharmaceutical leader Orion selects Determine to optimize their global Source-to-Contract effectiveness

Summary Orion Corp (Orion) is a developer of pharmaceuticals and diagnostic tests.The company develops, manufactures and markets human and veterinary pharmaceuticals, active pharmaceutical ingredients (APIs) and diagnostic tests. It focuses on developing pharmaceutical products for central nervous system disorders,...

  • Medical Device
  • Pharmaceutical
  • Finland
  • Company Financials
  • Orion Corporation

The Pharmaceuticals business' s net sales were up by ##% at EUR ##, ## (##, ##) million.

  • Clinical Trial
  • Pharmaceutical
  • Pulmonary Delivery
  • Therapy
  • Orion Corporation
  • 6.3 Orion Corporation
  • ORION CORPORATION NET SALES BY SEGMENTS; 2016

Its effectiveness is one-fifth of isoflurane.

  • Pharmaceutical
  • Europe
  • Company Financials
  • Demand
  • Orion Corporation
  • PARTNERSHIP - DEAL REPORTS
  • Partner 1

Partner ## Janssen Pharmaceuticals, Inc.

  • Healthcare
  • Pharmaceutical
  • United States
  • Company
  • Orion Corporation
  • PRIVATE EQUITY

In the future, the Orion Group will have only one reporting segment, pharmaceuticals business.

  • Medical Device
  • Medical Equipment
  • Pharmaceutical
  • Finland
  • Orion Corporation
  • Orion Oyj Snapshot
  • Orion Oyj - Company Statement

ARADES trial is sponsored by Orion Corporation Orion Pharma and Endo Pharmaceuticals.

  • Pharmaceutical
  • World
  • Company Financials
  • Company Operations
  • Orion Corporation